Cashu
Investor Sentiment Shifts on Johnson & Johnson Amid Bristol Myers Squibb's Clinical Trial Expansion
3 days ago
Stocks
Health Care
jnj
Johnson & Johnson
NYSE: JNJ
-0.58 (-0.29%)
201.9
USD
At close at Dec 05, 21:34 UTC
Overview
Loading chart...
Key Stats
Market Cap
486.32B
Dividend Yield
0.00%
P/E Ratio
19.36
EPS
5.84
Revenue
88.82B
Avg. Volume
8.41M
About
What does JNJ do?
Johnson & Johnson, headquartered in New Brunswick, New Jersey, employs 131,900 people and focuses on healthcare through its Innovative Medicine and MedTech segments. Innovative Medicine targets various therapeutic areas, while MedTech offers products for orthopedic and cardiovascular interventions.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.